Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/3/24 17:37 | 5/31/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D | 1 | S | -43 | 11.93 | 0 | -4 | 37 | D | ||||||||||||||||
3/4/24 17:25 | 8/7/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | 2 | S.d | -380 | 13.28 | 0 | -29 | -100 | 0 | D | ||||||||||||||
1/8/24 18:48 | 1/4/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | 6 | S.d | -696 | 15.01 | 0 | -46 | 50 | D | |||||||||||||||
1/4/24 19:04 | 1/2/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | 7 | S.d | -2,463 | 14.57 | 0 | -169 | 3 | D | |||||||||||||||
8/10/23 16:31 | 8/8/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D | 1 | S | -21,585 | 14.39 | 0 | -1,500 | 926 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |